COPDPredict is a CE-marked smart digital monitoring solution from NEPeSMO that allows individuals
living with chronic obstructive airways disease (COPD) and their healthcare team to predict the
onset of exacerbations (otherwise known as acute episodes or flare-ups) and prompt early
intervention, thus preventing unnecessary emergency department visits and hospitalisations.
COPDPredict™ is for use by individuals with a diagnosis of COPD with greater than or equal to 1
acute exacerbation of their COPD per year.
COPDPredict™ allows you to input, collect, log and track trend data from blue-tooth connected
suitable devices such as lung monitors in a home setting to share with a healthcare provider by
sending data to a secure clinician-facing website.
COPDPredict™ uses a combination of your-reported wellbeing scores, lung function and biomarker
levels to generate your own personal health profile. Exacerbation prediction algorithms determine
the potential risk of an exacerbation of COPD based on your data inputs. Your healthcare team can
then provide you with the tailored support and intervention you require closer to home. You can
also communicate regularly and securely with your healthcare team using the within-App messaging
facility.
In addition, COPDPredict™ offers you a suite of digital educational material on healthy living, inhaler
technique and pulmonary rehabilitation to help you self-manage your COPD and remain in control.
COPDPredict™ is registered with MHRA and is OWASP and DSP toolkit compliant.
NEPeSMO is a UK-registered healthcare technology company founded by respiratory physicians who
have worked with patients and clinicians to develop and deliver smart user-friendly self-monitoring
solutions for personalised respiratory care and treatment.
At the moment NEPeSMO interacts directly with healthcare providers to offer the COPDPredict™
service under a software-as-a-service agreement. If you are an individual living with COPD and
experience exacerbations of COPD and wish to use COPDPredict, you can only do this if your
healthcare team has signed up to our services and has registered you as a patient.
Please do contact us for further information on info@nepesmo.com or visit our website
www.nepesmo.com where you can view what COPDPredict™ does and how it works.
living with chronic obstructive airways disease (COPD) and their healthcare team to predict the
onset of exacerbations (otherwise known as acute episodes or flare-ups) and prompt early
intervention, thus preventing unnecessary emergency department visits and hospitalisations.
COPDPredict™ is for use by individuals with a diagnosis of COPD with greater than or equal to 1
acute exacerbation of their COPD per year.
COPDPredict™ allows you to input, collect, log and track trend data from blue-tooth connected
suitable devices such as lung monitors in a home setting to share with a healthcare provider by
sending data to a secure clinician-facing website.
COPDPredict™ uses a combination of your-reported wellbeing scores, lung function and biomarker
levels to generate your own personal health profile. Exacerbation prediction algorithms determine
the potential risk of an exacerbation of COPD based on your data inputs. Your healthcare team can
then provide you with the tailored support and intervention you require closer to home. You can
also communicate regularly and securely with your healthcare team using the within-App messaging
facility.
In addition, COPDPredict™ offers you a suite of digital educational material on healthy living, inhaler
technique and pulmonary rehabilitation to help you self-manage your COPD and remain in control.
COPDPredict™ is registered with MHRA and is OWASP and DSP toolkit compliant.
NEPeSMO is a UK-registered healthcare technology company founded by respiratory physicians who
have worked with patients and clinicians to develop and deliver smart user-friendly self-monitoring
solutions for personalised respiratory care and treatment.
At the moment NEPeSMO interacts directly with healthcare providers to offer the COPDPredict™
service under a software-as-a-service agreement. If you are an individual living with COPD and
experience exacerbations of COPD and wish to use COPDPredict, you can only do this if your
healthcare team has signed up to our services and has registered you as a patient.
Please do contact us for further information on info@nepesmo.com or visit our website
www.nepesmo.com where you can view what COPDPredict™ does and how it works.
Show More
